Thanks for posting. Cardio-oncology is an emerging field and I...

  1. 4,443 Posts.
    lightbulb Created with Sketch. 4584
    Thanks for posting.

    Cardio-oncology is an emerging field and I expect it will explode over the coming decade. It's not surprising COH aren't referencing circumstancial evidence and preclinical data, they can talk about world first cardio protective anti-cancer synergy when it's clinically validated... within about 12 months.

    Fun fact, COH attempted to patent Bisantrene after their independent research demonstrated a massive opportunity in the m6a space (outside cardio-oncology). Unfortunately, it was rejected as the IP was already owned by a little Aussie biotech that few have heard of, yet.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
0.000(0.00%)
Mkt cap ! $97.07M
Open High Low Value Volume
1.4¢ 1.4¢ 1.2¢ $304.8K 23.56M

Buyers (Bids)

No. Vol. Price($)
57 13718532 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 5374446 13
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.